Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Neurogenomics Industry?

In the last few years, the neurogenomics market has experienced a rapid expansion. The market value is projected to increase from $1.31 billion in 2024 to $1.50 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 15.0%. This expansion during the historic period was propelled by an increased demand for genetic testing for neurological conditions, enhanced research on the link between the brain, behavior, and genome, an escalation in the prevalence of neurodegenerative ailments, a rise in funding for neuroscience research, and an increase in both biobanks and genomic databases.

In the coming years, the neurogenomics market is predicted to experience a quick proliferation. It is projected to amplify to $2.60 billion by 2029 at a compound annual growth rate (CAGR) of 14.7%. The upward trend during the forecast period can be linked to the rising interest in customized treatments for mental health conditions, an increment in the utilization of direct-to-consumer neurogenetic testing, higher acceptance of multi-omics strategies, increased precision neurology initiatives, and a growing uptake of tailored therapies. The projection period sees key tendencies like the inception of artificial intelligence-powered genomic analysis, the creation of non-invasive diagnostic platforms, the amalgamation of multi-omics strategies, the integration of genomics into precision neurology, and advancements in neurodegenerative disease modeling.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25845&type=smp

What Forces Are Driving The Growth Of The Neurogenomics Industry?

The neurogenomics market is anticipated to experience significant growth due to the increasing incidence of neurological diseases. These medical conditions, which can affect the brain, spinal cord, or nerves, can cause symptoms like muscle weakness, seizures, pain, or cognitive impairments. Lifestyle factors like poor diet, insufficient exercise, chronic stress, and greater exposure to environmental toxins are primarily responsible for the high prevalence of neurological disorders. Neurogenomics offers a more comprehensive understanding of the genetic causes behind brain function and dysfunction, paving the way for accurate diagnosis and specific treatments for neurological disorders. For example, the Alzheimer’s Association, a nonprofit health organization in the US, reported in March 2023 that around 6.7 million Americans aged 65 and older were living with Alzheimer’s dementia. This statistic is expected to increase to 13.8 million by 2060. Hence, the growing incidence of neurological diseases is fueling the expansion of the neurogenomics market.

What Is The Overview Of Market Segmentation In The Neurogenomics Industry?

The neurogenomics market covered in this report is segmented –

1) By Offering: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Software And Services

2) By Application: Variant Discovery, Research Applications, Target Identification, Transcription Factor Binding Analysis, Functional Studies, Clinical Applications

3) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals And Diagnostic Laboratories

Subsegments:

1) By Next-Generation Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing, Ribonucleic Acid Sequencing

2) By Polymerase Chain Reaction: Real-Time Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Digital Polymerase Chain Reaction

3) By Microarray: Deoxyribonucleic Acid Microarray, Ribonucleic Acid Microarray, Protein Microarray

4) By Software And Services: Data Analysis And Interpretation Software, Genomic Data Management Tools, Custom Services, Cloud-Based Platforms And Reporting Tools

How Are Key Trends Driving Expansion In The Neurogenomics Industry?

Prominent firms in the neurogenomics market are concentrating on the development of sophisticated solutions like whole genome sequencing platforms. These advancements are designed to improve the diagnosis and comprehension of intricate neurological disorders. Whole genome sequencing platforms serve as devices for examining a person’s full DNA sequence, therefore uncovering genetic aspects associated with neurological conditions. For instance, Centogene N.V., a German firm that specializes in diagnosing and researching rare diseases, introduced CentoGenome in April 2023. This is universally esteemed as the most extensive whole-genome sequencing (WGS) solution for diagnosing rare and neurodegenerative conditions. The platform uses PCR-free technology for high-quality, impartial sequencing across sophisticated genetic regions. It further boosts variant detection with an advanced bioinformatics pipeline and specialist interpretation, pinpointing almost all illness-causing variants in a single test. It also delivers continuous diagnostic support throughout a patient’s life, including free variant reclassification and confirmatory testing as new scientific data emerges.

Who Are The Primary Players Operating Across The Global Neurogenomics Market?

Major companies operating in the neurogenomics market are F. Hoffmann-La Roche Limited, Thermo Fisher Scientific Incorporated, Danaher Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Myriad Genetics Inc., GeneDx LLC, Fulgent Genetics Inc., Oxford Nanopore Technologies Plc, Vigil Neuroscience Inc., PacBio, MedGenome Labs Ltd., MGI Tech Co. Ltd., Centogene N.V., Variantyx Inc., Neurogene.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/neurogenomics-global-market-report

Which Region Offers The Most Growth Potential For The Neurogenomics Market Through 2029?

North America was the largest region in the neurogenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurogenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25845&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model